Breast Cancer is a condition affecting many individuals worldwide. It cuts across regions, wealth status and medical advancement levels. Various treatments and interventions have been devised to fight the scourge. Unfortunately, no single method or entity has come up with specific treatment guideline. This gloomy scenario has resulted in more suffering and unnecessary fatalities. As of now, the medical fraternity cannot assure patients of complete breast cancer healing. But behind the scenes, Tempus, the cancer-fighting startup from Groupon founder Erick Lefkofsky is working hard to change this situation.The drawbacks in treating breast cancer arise from the numerous presentations, mutations and personal backgrounds. To tackle the breast cancer menace, Tempus has come up with a strategy to capture data from patients in all health facilities dealing with cancer. In partnership with the University of Chicago, Tempus will analyze data from over 1,000 cancer patients. This statistics will assist doctors in creating personalized treatment for each patient.
Diagnosis of Breast Cancer requires a paradigm that involves targeted therapeutics that exploits the immunological and molecular state of the tumor. Tempus primary focus is to collect and disseminate an acceptable model that doctors can use to match each patient’s molecular profile to their treatment.To realize this noble idea, the Precision Promise trial, organized by the Pancreatic Cancer Action Network (PanCAN) has tapped Tempus to use its disruptive technology in production and analysis of genomic and clinical data. By utilizing Tempus tools, thousands of breast cancer patients’ data will be collected and stored for clinical referencing. Physicians will use this technology in determining the molecular constitution of patient’s cells and focusing therapy on the genomic profile. This targeted treatment is expected to bring positive results to breast cancer patients.
Erick Lefkofsky is the co-founder and CEO of Tempus company. This technological company has created an operating system for collecting and preserving data from cancer patients. He graduated from the University of Michigan and received his Juris Doctor from the Universityof Michigan Law School. Also, he is the co-founder and chairman of Groupon and Uptake technologies.Mr. Lefkofsky together with his wife Liz has established the Lefkofsky Family Foundation. The charitable organization is improving the welfare of people in targeted communities.